𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Glutamic acid decarboxylase antibodies, autonomic nerve antibodies and autonomic neuropathy in diabetic patients

✍ Scribed by G. Sundkvist; L. A. Velloso; O. Kämpe; S. L. Rabinowe; S. A. Ivarsson; B. Lilja; F. A. Karlsson

Publisher
Springer
Year
1994
Tongue
English
Weight
859 KB
Volume
37
Category
Article
ISSN
0012-186X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antibodies to Glutamic Acid Decarboxylas
Antibodies to Glutamic Acid Decarboxylase in Japanese Diabetic Patients with Secondary Failure of Oral Hypoglycaemic Therapy
✍ Fukui, M.; Nakano, K.; Shigeta, H.; Yoshimori, K.; Fujii, M.; Kitagawa, Y.; Mori 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

Some patients with non-insulin-dependent (Type 2) diabetes mellitus (NIDDM) are positive for antibodies to glutamic acid decarboxylase (anti-GAD), which have been shown to be a useful marker for the diagnosis and prediction of insulin-dependent (Type 1) diabetes mellitus (IDDM). Anti-GAD positive NI

Glutamic acid decarboxylase antibodies i
Glutamic acid decarboxylase antibodies in idiopathic generalized epilepsy and type 1 diabetes
✍ Pasquale Striano; Giuseppe Perruolo; Luca Errichiello; Pietro Formisano; Frances 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 49 KB

colleagues' concern that there may be bias toward patients with more progressive disease in the control group compared with the treated group appears unlikely. The 20% of patients in the control group who had discontinued immunomodulatory or immunosuppressive treatment in the first 3 to 6 weeks bec

Autonomic neuropathy, QT interval length
Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients
✍ D. J. Ewing; O. Boland; J. M. M. Neilson; C. G. Cho; B. F. Clarke 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 469 KB

QT intervals were measured over RR intervals ranging from 500 ms to 1000 ms in 13 normal male subjects, 13 male diabetic subjects without and 13 with autonomic neuropathy. There was a close linear relationship between QT and RR in all subjects. The slope of the regression line was significantly grea

Elimination of islet cell antibodies and
Elimination of islet cell antibodies and glutamic acid decarboxylase antibodies II in a patient with newly diagnosed insulin-dependent diabetes mellitus
✍ W. O. Richter; M. G. Donner; P. Schwandt 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views

Islet cell antibodies and glutamic acid decarboxylase II (GAD II) antibodies have been discussed in the autoimmune pathogenesis of insulin-dependent diabetes mellitus (IDDM). Hence, immunosuppressants, intravenous immunoglobulins, and plasmapheresis have been used in an effort to modulate autoimmune